drugset / Trial / NCT01960205

Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity

NCT01960205

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to examine the effect of Saxagliptin in the newly diagnosed people with pre-diabetes and obesity besides lifestyle intervention ,there to evaluate DPP 4 inhibitors of reversing pre-diabetes curative effect to normal blood sugar, and observe its influences on the targets of obesity related metabolic abnormalities, to explore new ways for intervention on populations with pre-diabetes and obesity .

Timeline

Start
2013-08
Primary completion
2014-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg
Subject SAXAGLIPTIN ANHYDROUS Small molecule 2.5 mg
Subject SAXAGLIPTIN ANHYDROUS Small molecule 5 mg

Indications